The number of people with chronic pain has increased substantially in recent years, and the reason isn’t completely clear. A ...

Pain management has seen a profound transformation in recent years, driven by advancements in regenerative medicine and ...

A systematic review and meta-analysis found some supporting evidence for transdermal anti-inflammatory patches, but the ...

The blood-brain barrier (BBB) is a major hurdle for the development of systemically delivered drugs targeting diseases of the central nervous system (CNS). Because of this barrier there is a huge ...

Participants Patients on repeat prescribed pain medication (4815) were screened by general practitioners (GPs ... understanding of the polypharmacy regimens12 frequently used in chronic pain ...

Continuing progress in the research of new drugs for chronic and serious diseases ... 2025 could mark a turning point in pain management. U.S. regulators are expected to complete their review ...

Paracetamol, also known as acetaminophen, is one of the most commonly used painkillers worldwide. It’s often recommended as a ...

Back pain is a widespread issue that affects millions of individuals across the globe. Whether it's from sitting too long at ...

Back pain is the most common complaint in a pain management clinic ... thermal RFA of the DRG is not effective in the treatment of chronic lumbar radicular pain. The trial results provided ...

Kidney stones and diarrhea both affect organ systems in the upper and lower abdomen. Learn how symptoms overlap and how to ...

Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, including insulin for diabetes, and face no costs whatsoever for similar generic options under a ...

SX-682 is under clinical development by Syntrix Pharmaceuticals and currently in Phase II for Non-Small Cell Lung Cancer.